Document Detail


Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
MedLine Citation:
PMID:  23299706     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this study was to evaluate among postmenopausal women the effects of a 3-month treatment with estradiol (E2) alone or in combination with norethindrone acetate (NA) on expression of hormone receptors and proliferation in the breast as well as on lipids and climacteric symptoms. METHODS: Sixty healthy postmenopausal women were computer-randomized into two groups, with one group receiving 1 mg of E2 and the other group receiving 1 mg of E2 and 0.5 mg of NA daily for 12 weeks. Before and after treatment, middle-needle biopsies were obtained for histology and investigation of the expression levels of estrogen receptors (ERs; ER-α and ER-β), progesterone receptors (PRs; PR-A and PR-B), androgen receptor (AR), the proliferation marker Ki67, and collagen. Climacteric symptoms were recorded, and serum was collected to measure lipoprotein levels. RESULTS: Fifty-six women finished the 12-week study. Proliferating cells (Ki67-positive) were very rare in all but a few of the untreated women. There were proliferating cells in both E2- and E2/NA-treated groups; however, these were not widespread and limited to nests of cells that amounted to 2% of the total epithelial cells. Some of these nests were positive for human epithelial growth factor receptor 2. Treatments caused no marked changes in the expression of ER-α, ER-β, or AR. However, both treatments resulted in an increase in PR-A and PR-B expressions. The presence of collagen was clearly associated with a mammographic diagnosis of dense breasts, but neither hormone treatment affected breast density. Both E2 and E2/NA treatments were effective in relieving hot flashes and sweating without adverse effects on blood pressure, weight, and liver, kidney, and thyroid functions. A decrease in cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol was induced by E2/NA but not by E2. CONCLUSIONS: This short-term prospective study shows that E2 and estrogen-progestogen treatment can up-regulate PRs but do not significantly affect ERs, AR, proliferation, or breast density.
Authors:
Guojun Cheng; Ryan Butler; Margaret Warner; Jan-Åke Gustafsson; Brigitte Wilczek; Britt-Marie Landgren
Related Documents :
17471536 - Cytoskeletal elements and intracellular transport.
4296 - Distribution of releasing factors, biogenic amines, and related enzymes in the bovine m...
24048386 - Clinical potential of cariprazine in the treatment of acute mania.
1917956 - Phosphorylation of transfected wild type and mutated progesterone receptors.
10841076 - Structure-function study of the extracellular domain of the human type i interferon rec...
6269856 - Early events following the binding of epidermal growth factor to surface receptors on o...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-7
Journal Detail:
Title:  Menopause (New York, N.Y.)     Volume:  -     ISSN:  1530-0374     ISO Abbreviation:  Menopause     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433353     Medline TA:  Menopause     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the 1Department of Biosciences and Nutrition, Karolinska Institutet, Novum, Sweden; 2Division of Obstetrics and Gynecology, Department of Clinical Science, Karolinska University Hospital at Huddinge, Stockholm, Sweden; 3Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX; and 4Unilabs Mammography Department, Capio St. Görans Hospital, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drug-Eluting Nitinol Stent Treatment of the Superficial Femoral Artery and Above-the-Knee Popliteal ...
Next Document:  One-pot synthesis of branched palladium nanodendrites with superior electrocatalytic performance.